THE BROAD INSTITUTE, INC.;THE GENERAL HOSPITAL CORPORATION;PRESIDENT AND FELLOWS OF HARVARD COLLEGE;BAYER PHARMA AKTIENGESELLSCHAFT
发明人:
David B. Sykes,David Scadden,Timothy A. Lewis,Andreas Janzer,Hanna Meyer,Detlef Stöckigt
申请号：
US15756469
公开号：
US20180263970A1
申请日:
2016.08.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2′-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid).
